Retour
Prix Keymed Biosciences Inc. (02162.HK)
Graphique du cours de l'action 02162.HK
KEYMED BIO-B (02162.HK)
Keymed Biosciences Inc.
HK$54.35
0%
$0
Marché fermé: Mar 17, 16:00:00 HKT
Statistiques clés
Clôture préc.
$54.35
Prix d'ouverture
$54.35
Plage de la journée
$53.6 - $55.85
Plage de 52 semaines
$33.8 - $80
Volume
275.0K
Volume moyen
1.4M
BPA (TTM)
-1.12
Rendement en dividend
--
Capitalisation boursière
$16.3B
Qu’est-ce que KEYMED BIO-B ?
Keymed Biosciences, Inc. is an investment holding company, which engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas. The company is headquartered in Chengdu, Sichuan and currently employs 1,469 full-time employees. The company went IPO on 2021-07-08. The firm also focused on the research and development of pharmaceutical products. The firm's main products comprise CM310, CM326, CM313 and CM383, mainly used for treating various type II immunological diseases in adults, adolescents and children, including moderate-to-severe atopic dermatitis (AD), moderate-to-severe asthma, CRSwNP, AR and potentially COP. The firm has also established a fully integrated platform covering the key functions of biopharmaceutical development. The firm mainly conducts its businesses in the domestic market and overseas markets.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.
